Darby International Invests in Peru’s IBT Health
Darby International Capital has made an undisclosed investment in Peru-based healthcare operations provider IBT Health. Read more… Read More
Darby International Capital has made an undisclosed investment in Peru-based healthcare operations provider IBT Health. Read more… Read More
Partech Partners led a USD6.5m Series B for Almentor, a Dubai-based video learning platform targeting Arabic speakers, with participation from Sawari Ventures, Sango Capital and Egypt Ventures. Read more… Read More
L Catterton led a USD40m Series B for Singapore-based D2C dental products company Zenyum, with follow-on from Sequoia Capital India, RTP Global, Partech, TNB Aura, Seeds Capital and FEBE Ventures. L Catterton invested USD25m in the round. Read more… Read More
Accel Partners, Falcon Edge Capital, Norwest Venture Partners and angel investors have invested a USD50m Series A for Mensa Brands, an India-based D2C startup which acquires online-first brands. The round included a debt component provided by Alteria Capital and InnoVen Capital. Read more… Read More
Sequoia Capital China and Yunfeng Capital led a CNY1.45b (~USD228m) Series B for China-based rice brand Shiyue Daotian, with participation from CMC Capital Group and Taihecap, and follow-on from GenBridge Capital. Read more… Read More
Tiger Global Management led a USD15.6m Series A for India-based health insurance startup Plum Insurance, with follow-on from Sequoia Capital India’s Surge, Tanglin Venture Partners, Incubate Fund and Gemba Capital. Read more… Read More
Fidelity Investments led a USD277m Series H for India-based e-commerce logistics company Delhivery, with participation from GIC, Chimera Investments and Baillie Gifford. Read more… Read More
Ninety One has sold Silica, a South Africa-based provider of third-party administration and related technology solutions to asset managers and investment product providers, to global wealth management platform FNZ. Read more… Read More
Glory Ventures has reached a USD120m final close for its second China-focused venture fund targeting investments in tech infrastructure and applications. Read more… Read More
Yingke Private Equity has reached a CNY10b (~USD1.6b) final close for its latest CNY-denominated fund targeting investments in biomedicine and hard technology sectors. Yingke PE also recently closed its third USD-denominated fund. Read more… Read More
(default archive template)